ReActiv8, which treats back pain, treats chronic back pain, recently received the CE mark of approval.
Here are five things to know:
1. ReActiv8 is an implantable neurostimulation system designed to treat chronic low back pain.
2. Francis Kilian, MD, an orthopedic surgeon and neurosurgeon at the Catholic Hospital Koblenz-Montabaur in Koblenz, Germany, performed the first implant.
3. Dr. Kilian said that ReActiv8 is exactly what patients who aren't candidates for spine surgery need.
4. ReActiv8 electrically stimulates the nerves responsible for contracting the stabilizing muscles of the lumbar spine. Activating these muscles to restore functional spine stability has facilitated a patients' recovery from CLBP.
5. Mainstay is based in Dublin and has most of its commercial activities focused on Germany, where it hopes to popularize ReActiv8 before expanding to other countries and clinics.
More device-related articles:
Inspired by her own condition, Duke graduate founds neurological disorders company: 5 highlights
Virginia Spine Institute perform Mid-Atlantic region's 1st Mazor X surgery — 5 takeaways
Biogen pays Ionis $5M under neurologic disease drug collaboration: 5 insights